Company Profiles

driven by the PitchBook Platform

Interface Biologics

Description

Developer of transformative biomedical polymer technology. The company focuses on developing anti-thrombogenic additives and programmable combination drug delivery devices.

2001

Founded

PRIVATE

Status

11-50

Employees

Series B

Latest Deal Type

$6.23M

Latest Deal Amount

$27.5M

Total Amount Raised

Description

Developer of transformative biomedical polymer technology. The company focuses on developing anti-thrombogenic additives and programmable combination drug delivery devices.

Website:

www.interfacebiologics.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Other Devices and Supplies

Other Industries

Biotechnology
Laboratory Services (Healthcare)

Primary Office

MaRS Centre, South Tower 101 College Street, Suite 300 Toronto, Ontario M5G 1L7Canada +1 (416) 673-8170
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Interface Biologics's full profile, request a free trial.

Interface Biologics Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Interface Biologics Investors (8)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
BDC Healthcare Venture FundVenture CapitalMinority000 0000000 0000
Covington CapitalVenture CapitalMinority000 0000000 0000
DSM VenturingCorporate Venture CapitalMinority000 0000000 0000
Genesys CapitalVenture CapitalMinority000 0000000 0000
MaRS Discovery DistrictAccelerator/IncubatorMinority000 0000000 0000
BDC Healthcare Venture Fund Venture Capital
Covington Capital Venture Capital
DSM Venturing Corporate Venture Capital
Genesys Capital Venture Capital
MaRS Discovery District Accelerator/Incubator

Interface Biologics Executive Team (7)

NameTitleBoard
Seat
Contact
Info
Thomas ReevesPresident, Chief Executive Officer & Board Member
Paul Santerre Ph.DFounder, Chief Scientific Officer & Board Member
Defne GarnerDirector, Finance
Mark SteedmanVice President, Business Development
Jeannette HoVice President, Operations
Thomas Reeves President, Chief Executive Officer & Board Member
Paul Santerre Ph.D Founder, Chief Scientific Officer & Board Member
Defne Garner Director, Finance
Mark Steedman Vice President, Business Development
Jeannette Ho Vice President, Operations

Interface Biologics Board Members (11)

NameRepresentingRoleSinceContact
Info
Amine BenmoussaBDC Healthcare Venture FundPrincipal000 0000
Arthur Rosenthal Ph.DSelfChairman000 0000
Cynthia Lavoie Ph.DSelfBoard Member000 0000
Denis HoSelfBoard Member000 0000
Dion MadsenBDC Healthcare Venture FundSenior Managing Partner000 0000
Amine Benmoussa Principal BDC Healthcare Venture Fund
Arthur Rosenthal Ph.D Chairman Self
Cynthia Lavoie Ph.D Board Member Self
Denis Ho Board Member Self
Dion Madsen Senior Managing Partner BDC Healthcare Venture Fund
Request full access to PitchBook